NuvoAir Partners With Global Pharmaceutical Company to Help Physicians Early Diagnose and Monitor Respiratory Patients

NuvoAir spirometry test

NuvoAir (formerly called Pond Healthcare Innovation), the company commercializing the Air Smart Spirometer, announced today a partnership with Novartis Pharma AG to distribute NuvoAir’s spirometry technology to physicians worldwide. This partnership solidifies NuvoAir’s position as the leading mobile spirometry platform and Novartis’ commitment to address the unmet medical needs of respiratory patients.

"We are extremely delighted about the opportunity to strengthen the relationship we have with the Respiratory Franchise at Novartis. This partnership is highly synergistic," says Lorenzo Consoli CEO at NuvoAir. “When you combine the speed and innovation of a startup with the resources and scale of a multinational organization you can bring great products to millions of people around the world.”

Respiratory diseases cause an immense worldwide health burden and the cost to society is worth billions of dollars. Late diagnosis, which in COPD can be up to several years, and lack of effective monitoring tools are two important contributors to this immense health burden.

NuvoAir’s technology and compelling design can make a real difference to the millions of people suffering from respiratory diseases. Spirometers have been traditionally bulky and complex devices used in hospital settings by trained personnel. "Air Smart has simplified spirometry bringing it directly to the hands of patients and physicians worldwide. Our technology can help bridging the communication gap between patients and physicians, thus improving the quality of care," says Lorenzo Consoli.

The Air Smart Spirometer is the first ultra-portable spirometer connected to a smartphone. Launched in Europe in 2016, Air Smart has very quickly reached strong success in the market, with thousands of units sold among physicians and patients in over 20 countries. The device won numerous design awards including the Red Dot Design Award and the Design S Award in 2016.

Air Smart Spirometer is a CE-certified, class IIa medical device, developed according to ISO 26782:2009. 

Source: NuvoAir


Categories: Healthcare, Chronic Diseases, Diagnostics

Tags: Asthma, COPD, Cystic Fibrosis, Digital Health, Novartis, NuvoAir, Spirometer, Telehealth


Related Video

Additional Images

About NuvoAir AB

View Website

NuvoAir is a digital therapeutics company dedicated to improving the lives of those affected by respiratory conditions. NuvoAir connected ecosystem makes sense of patient data to guide a more personalised approach to improving health-related outcomes

Lorenzo Consoli
CEO, NuvoAir AB
NuvoAir AB
Riddargatan 17D
Stockholm, Sweden 114 57